• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UCHL5 的催化结构域的晶体结构,一种与蛋白酶体相关的人类去泛素化酶,揭示了该酶的一种非生产形式。

Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme.

机构信息

Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA.

出版信息

FEBS J. 2011 Dec;278(24):4917-26. doi: 10.1111/j.1742-4658.2011.08393.x. Epub 2011 Nov 11.

DOI:10.1111/j.1742-4658.2011.08393.x
PMID:21995438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3336103/
Abstract

Ubiquitin carboxy-terminal hydrolase L5 (UCHL5) is a proteasome-associated deubiquitinating enzyme, which, along with RPN11 and USP14, is known to carry out deubiquitination on proteasome. As a member of the ubiquitin carboxy-terminal hydrolase (UCH) family, UCHL5 is unusual because, unlike UCHL1 and UCHL3, it can process polyubiquitin chain. However, it does so only when it is bound to the proteasome; in its free form, it is capable of releasing only relatively small leaving groups from the C-terminus of ubiquitin. Such a behavior might suggest at least two catalytically distinct forms of the enzyme, an apo form incapable of chain processing activity, and a proteasome-induced activated form capable of cleaving polyubiquitin chain. Through the crystal structure analysis of two truncated constructs representing the catalytic domain (UCH domain) of this enzyme, we were able to visualize a state of this enzyme that we interpret as its inactive form, because the catalytic cysteine appears to be in an unproductive orientation. While this work was in progress, the structure of a different construct representing the UCH domain was reported; however, in that work the structure reported was that of an inactive mutant [catalytic Cys to Ala; Nishio K et al. (2009) Biochem Biophys Res Commun 390, 855-860], which precluded the observation that we are reporting here. Additionally, our structures reveal conformationally dynamic parts of the enzyme that may play a role in the structural transition to the more active form.

摘要

泛素羧基末端水解酶 L5(UCHL5)是一种与蛋白酶体相关的去泛素化酶,与 RPN11 和 USP14 一起,已知可在蛋白酶体上进行去泛素化。作为泛素羧基末端水解酶(UCH)家族的一员,UCHL5 很不寻常,因为与 UCHL1 和 UCHL3 不同,它可以处理多泛素链。然而,只有当它与蛋白酶体结合时才会这样做;在其游离形式下,它只能从泛素的 C 末端释放相对较小的离去基团。这种行为可能表明该酶至少有两种催化上不同的形式,一种是不能进行链处理活性的脱辅基形式,另一种是蛋白酶体诱导的激活形式,能够切割多泛素链。通过对代表该酶催化结构域(UCH 结构域)的两个截断构建体的晶体结构分析,我们能够可视化该酶的一种状态,我们将其解释为其无活性形式,因为催化半胱氨酸似乎处于非生产性取向。在这项工作进行的过程中,报道了另一种代表 UCH 结构域的不同构建体的结构;然而,在那项工作中,报道的结构是无活性突变体[catalytic Cys to Ala;Nishio K 等人。(2009)生物化学与生物物理研究通讯 390,855-860],这排除了我们在这里报告的观察结果。此外,我们的结构揭示了酶的构象动态部分,它们可能在向更活跃形式的结构转变中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fe/3336103/1dfbe37a2911/nihms331905f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fe/3336103/a0ed5d6cf62f/nihms331905f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fe/3336103/3c52352d6ba7/nihms331905f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fe/3336103/74b0230c5a35/nihms331905f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fe/3336103/1dfbe37a2911/nihms331905f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fe/3336103/a0ed5d6cf62f/nihms331905f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fe/3336103/3c52352d6ba7/nihms331905f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fe/3336103/74b0230c5a35/nihms331905f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fe/3336103/1dfbe37a2911/nihms331905f4.jpg

相似文献

1
Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme.UCHL5 的催化结构域的晶体结构,一种与蛋白酶体相关的人类去泛素化酶,揭示了该酶的一种非生产形式。
FEBS J. 2011 Dec;278(24):4917-26. doi: 10.1111/j.1742-4658.2011.08393.x. Epub 2011 Nov 11.
2
Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain.去泛素化酶UCH37(人UCH-L5)催化结构域的晶体结构。
Biochem Biophys Res Commun. 2009 Dec 18;390(3):855-60. doi: 10.1016/j.bbrc.2009.10.062. Epub 2009 Oct 20.
3
Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14.蛋白酶体相关去泛素化酶USP14的结构与机制
EMBO J. 2005 Nov 2;24(21):3747-56. doi: 10.1038/sj.emboj.7600832. Epub 2005 Oct 6.
4
Stabilization of an unusual salt bridge in ubiquitin by the extra C-terminal domain of the proteasome-associated deubiquitinase UCH37 as a mechanism of its exo specificity.蛋白酶体相关去泛素化酶UCH37 的额外 C 末端结构域稳定泛素中的一种不寻常盐桥,作为其外切特异性的机制。
Biochemistry. 2013 May 21;52(20):3564-78. doi: 10.1021/bi4003106. Epub 2013 May 9.
5
The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK).泛素羧基末端水解酶 L1(UCHL1)与三肽氟甲基酮(Z-VAE(OMe)-FMK)的共晶结构。
Bioorg Med Chem Lett. 2012 Jun 15;22(12):3900-4. doi: 10.1016/j.bmcl.2012.04.124. Epub 2012 May 4.
6
Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells.USP14 和 UCHL5 的失活会导致哺乳动物细胞中不同的泛素化蛋白积累。
PLoS One. 2019 Nov 8;14(11):e0225145. doi: 10.1371/journal.pone.0225145. eCollection 2019.
7
Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1.Adrm1介导蛋白酶体招募并激活Uch37去泛素化酶。
Nat Cell Biol. 2006 Sep;8(9):994-1002. doi: 10.1038/ncb1460. Epub 2006 Aug 13.
8
Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.蛋白酶体相关半胱氨酸去泛素化酶是环境光增白剂化合物的分子靶标。
J Cell Biochem. 2019 Aug;120(8):14065-14075. doi: 10.1002/jcb.28682. Epub 2019 Apr 8.
9
Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes.蛋白酶体相关去泛素化酶对泛素链的修剪。
Mol Cell Proteomics. 2011 May;10(5):R110.003871. doi: 10.1074/mcp.R110.003871. Epub 2010 Sep 7.
10
Ubiquitin recognition of BAP1: understanding its enzymatic function.泛素对 BAP1 的识别:理解其酶学功能。
Biosci Rep. 2017 Oct 27;37(5). doi: 10.1042/BSR20171099. Print 2017 Oct 31.

引用本文的文献

1
Comprehensive pan-cancer analysis indicates UCHL5 as a novel cancer biomarker and promotes cervical cancer progression through the Wnt signaling pathway.全面的泛癌分析表明UCHL5是一种新型癌症生物标志物,并通过Wnt信号通路促进宫颈癌进展。
Biol Direct. 2024 Dec 19;19(1):139. doi: 10.1186/s13062-024-00588-6.
2
Deubiquitinases in Ovarian Cancer: Role in Drug Resistance and Tumor Aggressiveness.去泛素化酶在卵巢癌中的作用:与耐药性和肿瘤侵袭性的关系。
Int J Biol Sci. 2024 Sep 23;20(13):5208-5222. doi: 10.7150/ijbs.100355. eCollection 2024.
3
Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them.泛素羧基末端水解酶(UCH)家族去泛素化酶在肿瘤发生中的潜在作用以及针对它们开发的化学抑制剂。
Am J Cancer Res. 2024 Jun 15;14(6):2666-2694. doi: 10.62347/OEGE2648. eCollection 2024.
4
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.药物2c及其衍生物对卵巢癌细胞作用的体外和体内评价
Pharmaceutics. 2024 May 15;16(5):664. doi: 10.3390/pharmaceutics16050664.
5
Altered Protein Dynamics and a More Reactive Catalytic Cysteine in a Neurodegeneration-associated UCHL1 Mutant.与神经退行性疾病相关的 UCHL1 突变体中蛋白动力学改变和催化半胱氨酸更具反应性。
J Mol Biol. 2024 Feb 15;436(4):168438. doi: 10.1016/j.jmb.2024.168438. Epub 2024 Jan 5.
6
Genetically Encoded Crosslinking Enables Identification of Multivalent Ubiquitin-Deubiquitylating Enzyme Interactions.基因编码交联技术可用于鉴定多价泛素-去泛素化酶相互作用。
Chembiochem. 2023 Aug 1;24(15):e202300305. doi: 10.1002/cbic.202300305. Epub 2023 Jul 7.
7
The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.去泛素化酶(DUBs)在寄生虫中的新兴作用:前瞻性综述。
Front Cell Infect Microbiol. 2022 Sep 27;12:985178. doi: 10.3389/fcimb.2022.985178. eCollection 2022.
8
Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response.去泛素化酶(DUBs):调控、动态平衡和氧化应激反应。
J Biol Chem. 2021 Sep;297(3):101077. doi: 10.1016/j.jbc.2021.101077. Epub 2021 Aug 12.
9
Functional characterisation guides classification of novel germline variants.功能特征描述指导新型种系变体的分类。
NPJ Genom Med. 2020 Nov 19;5:50. doi: 10.1038/s41525-020-00157-6. eCollection 2020.
10
Molecular Regulation of the Polycomb Repressive-Deubiquitinase.多梳抑制-去泛素酶的分子调控。
Int J Mol Sci. 2020 Oct 22;21(21):7837. doi: 10.3390/ijms21217837.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
REFMAC5 for the refinement of macromolecular crystal structures.用于大分子晶体结构精修的REFMAC5
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67. doi: 10.1107/S0907444911001314. Epub 2011 Mar 18.
3
Mechanism, specificity and structure of the deubiquitinases.去泛素化酶的作用机制、特异性和结构
Subcell Biochem. 2010;54:69-87. doi: 10.1007/978-1-4419-6676-6_6.
4
Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes.蛋白酶体相关去泛素化酶对泛素链的修剪。
Mol Cell Proteomics. 2011 May;10(5):R110.003871. doi: 10.1074/mcp.R110.003871. Epub 2010 Sep 7.
5
Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation.泛素乙烯基甲酯结合将未对准的泛素水解酶UCHL1 的活性位点定向到生产性构象。
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9117-22. doi: 10.1073/pnas.0910870107. Epub 2010 May 3.
6
Features and development of Coot.Coot的特点与发展
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. doi: 10.1107/S0907444910007493. Epub 2010 Mar 24.
7
PHENIX: a comprehensive Python-based system for macromolecular structure solution.PHENIX:一个基于Python的用于大分子结构解析的综合系统。
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21. doi: 10.1107/S0907444909052925. Epub 2010 Jan 22.
8
MEROPS: the peptidase database.MEROPs:肽酶数据库。
Nucleic Acids Res. 2010 Jan;38(Database issue):D227-33. doi: 10.1093/nar/gkp971. Epub 2009 Nov 5.
9
Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain.去泛素化酶UCH37(人UCH-L5)催化结构域的晶体结构。
Biochem Biophys Res Commun. 2009 Dec 18;390(3):855-60. doi: 10.1016/j.bbrc.2009.10.062. Epub 2009 Oct 20.
10
DUBs at a glance.泛素特异性蛋白酶简介。
J Cell Sci. 2009 Jul 15;122(Pt 14):2325-9. doi: 10.1242/jcs.041046.